1-5 of 5
Jaroslava Voglova, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

"Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial

Susanne Saussele, MD, Johan Richter, MD PhD, Joelle Guilhot, PhD, Henrik Hjorth-Hansen, MD, Antonio Medina de Almeida, MD PhD, Jeroen J. W. M. Janssen, MD, Jiri Mayer, Prof, MD SCs, Perttu Koskenvesa, MD, Panayiotis Panayiotidis, MD PhD, Ulla Olsson-Strömberg, MD PhD, Juan Luis Steegmann, MD PhD, Hanne Vestergaard, MD, Hans Ehrencrona, MD PhD, Veli Kairisto, Kateřina Machová Poláková, PhD, Martin Müller, MD, Satu Mustjoki, MDPhD, Marc G. Berger, MD PhD, Philippe Rousselot, Martine Escoffre-Barbe, MD, Gabriel Etienne, MD PhD, Jolanta Dengler, MD, Françoise Rigal-Huguet, MD, Nikolas von Bubnoff, MD, Hana Klamova, MD, Edgar Faber, MD, François Guilhot, MD, Kourosh Lotfi, MD, Delphine Rea, MD, Tim H. Brümmendorf, MD, Gorgine de Greef, MD, Leif Stenke, MD, Franck Emmanuel Nicolini, MD PhD, Laurence Legros, MD PhD, Andreas Burchert, MD, Jaroslava Voglová, MD, Aude Charbonnier, MD, Emmanuel Gyan, MDPhD, Maria-Elisabeth Goebeler, MD, Peter E. Westerweel, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 313.
https://doi.org/10.1182/blood.V130.Suppl_1.313.313
Published: 2017
Journal Articles

Single-Cell Immune Signatures in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Treated with Nilotinib: An ENEST1st Sub Study

Stein-Erik Gullaksen, MSc, Jørn Skavland, PhD, Krzysztof Warzocha, MD PhD, Sonia Gavasso, PhD, Vinko Tosevski, PhD, Noortje Thielen, MDPhD, Jaroslava Voglova, MD, Augustin Ferrant, MD PhD, Werner Linkesch, MD, Josef Thaler, MD, Alois Lang, MD, Jesper Stentoft, Tobias Gedde-Dahl, MDPhD, Henrik Hjorth-Hansen, MD PhD, Waleed Majeed, MD, Gregor Verhoef, MD PhD, Andrzej Hellmann, MD PhD, Georgi G. Mihaylov, MD PhD, Claudia Dumrese, PhD, Frank Giles, MDMB, Andreas Hochhaus, MD, Sieghart Sopper, PhD, Leif Stenke, MD PhD, Boris Labar, MD PhD, Jeroen Janssen, MD, Kimmo Porkka, MD PhD, Gert J. Ossenkoppele, MD PhD, Satu Mustjoki, MD PhD, Dominik Wolf, MD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4022.
https://doi.org/10.1182/blood.V126.23.4022.4022
Published: 2015
Journal Articles

Early PK-Analysis Predicts Molecular Response In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib

Dominik Wolf, MD, Jorn Skavland, PhD, Christoph Seger, PhD, Sieghart Sopper, PhD, Wiktor-Wieslaw Jedrzejczak, MD, PhD, Dubravka Sertic, MD, Jaroslava Voglova, MD, Satu Mustjoki, MD PhD, Leif Stenke, MD, PhD, Augustin Ferrant, MD, PhD, Richard Greil, MD, Alois Lang, MD, Josef Thaler, MD, PhD, Werner Linkesch, MD, Antica Duletić-Načinović, MD , PhD, Andrzej Hellmann, MD, PhD, Georgi G. Mihaylov, MD, PhD, Tobias Gedde-Dahl, III, MD, PhD, Henrik Hjorth-Hansen, MD, PhD, Waleed Majeed, MD, Jesper Stentoft, MD, Gregor Verhoef, M.D. Ph.D., Jan Van Droogenbroeck, MD, Ute Mark, Jens Haenig, Nidas Jurjonas, Frank Giles, MD MB, Andreas Hochhaus, MD, Kimmo Porkka, MD, PhD, Gert J. Ossenkoppele, MD PhD, Bjorn T. Gjertsen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1485.
https://doi.org/10.1182/blood.V122.21.1485.1485
Published: 2013
Journal Articles

Interferon Alpha Treated Patients with Chronic Myeloid Leukemia (CML) In Prolonged Complete Remission Have Increased Numbers of NK-Cells and Clonal Gamma-Delta T-Cells, and a Distinct Plasma Cytokine Profile.

Anna Kreutzman, MSc, Peter Rohon, MD, Edgar Faber, MD, PhD, Karel Indrak, MD, PhD, Vesa Juvonen, PhD, Veli Kairisto, MD, PhD, Jaroslava Voglova, MD, Marjatta Sinisalo, MD, PhD, Emilia Flochova, MD, PhD, Petteri Arstila, MD, PhD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1201.
https://doi.org/10.1182/blood.V116.21.1201.1201
Published: 2010
Journal Articles

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.

Hana Klamova, Daniela Zackova, Edgar Faber, MD, PhD, Katerina Steinerova, Michal Karas, Eva Demeckova, Jaroslava Voglova, MD, Ludmila Demitrovicova, Elena Tothova, Juraj Chudej, MD, Imrich Markuljak, Tomas Kozak, Eduard Cmunt, M.D., Ph.D., Marie Jarosova, Katerina Machova-Polakova, Kyra Michalova, PhD, DSc, Ladislav Dusek, Jan Muzik, Martin Mistrik, Jiri Mayer, MD, PhD, Marek Trneny, MD, PhD, Karel Indrak, MD., PhD.
Journal: Blood
Blood (2010) 116 (21): 1239.
https://doi.org/10.1182/blood.V116.21.1239.1239
Published: 2010